AI in Telemedicine Market – Global Forecast To 2030
AI 기반 원격 진료 시장 – 구성 요소(소프트웨어, 서비스), 기능(가상 관리, 채팅봇, RPM, 관리, 환자 참여), 용도(원격 신경학, 원격 ICU, 원격 방사선학), 최종 사용자(공급자, 지불자, 환자) – 2030년까지의 세계 예측
AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) – Global Forecast to 2030
| 조사회사 | MarketsandMarkets |
| 출판년월 | 2025년7월 |
| 페이지 수 | 385 |
| 도표 수 | 467 |
| 라이센스 | Single User License |
| 가격 | USD 4,950 |
| 구성 | 영문조사보고서 |
이 연구 보고서는 하드웨어, 소프트웨어(모달리티별: EHR 중심, 비EHR 중심), 통합 유형별: 통합 소프트웨어, 독립형 소프트웨어), 배포별: 온프레미스 배포, 클라우드 기반 배포 등의 구성요소로, 가상 케어 컨설팅, 챗봇 및 가상 비서, 원격 환자 모니터링, 가상 간호 플랫폼, 임상 문서화, 관리 워크플로, 분석 및 보고, 환자 참여 및 기타 기능 등의 기능별로, 응용 프로그램별(1차 진료, 전문 진료{원격 방사선과, 원격 심장과, 원격 신경과, 당뇨병, 호흡기 질환, 고혈압, 원격 피부과, 원격 정신과, 기타 전문 진료 응용 프로그램}, 원격 ICU 및 기타 응용 프로그램) 등으로, 최종 사용자별로 의료 서비스 제공자{병원, 외래 수술 센터, 외래 진료 센터 및 기타 외래 환자 진료소, 장기 요양 및 보조 생활 시설, 가정 의료 서비스 등} 등으로 분류합니다. 및 기타 의료 서비스 제공자, 의료비 지불자, 환자, 제약 및 생명공학 회사, 의료 기술 회사 및 기타 최종 사용자] 및 지역.
본 보고서는 AI 기반 원격 진료 시장 성장에 영향을 미치는 주요 요인(동인, 제약, 과제, 기회 등)에 대한 자세한 정보를 다룹니다. 주요 업계 참여자에 대한 심층 분석을 통해 인수, 협업, 파트너십, 합병, 제품/서비스 출시 및 개선, AI 원격진료 및 원격의료 시장 승인 등 사업 개요, 제공 서비스, 주요 전략에 대한 통찰력을 제공합니다. 본 보고서는 AI 원격진료 및 원격의료 시장 생태계에서 유망한 스타트업에 대한 경쟁 분석을 다룹니다.
The global AI in telehealth & telemedicine market is projected to grow at a CAGR of 36.4% between 2024 and 2030. The AI in telehealth & telemedicine market is rapidly expanding due to various factors such as advancements in telecommunication technologies, favorable government support and regulatory policies, and the expansion of RPM systems. An increase in the geriatric population necessitates the continuous monitoring of chronic conditions, creating a growing demand for cost-effective healthcare solutions. An increasing focus on the diagnosis of chronic illnesses such as diabetes and heart disease has led to an increased need for telehealth devices. AI technologies such as virtual assistants, predictive analytics, and automated note-taking help improve the effectiveness and availability of telehealth services. For instance, in March 2025, Eli Lilly and Company (US) introduced LillyDirect remote consultations to diagnose and treat Alzheimer’s. Telehealth devices solve problems such as a lack of specialists and patient wait times, improving healthcare and patient access to advanced medical solutions.
전 세계 원격 진료 및 원격 의료 AI 시장은 2024년부터 2030년까지 연평균 성장률(CAGR) 36.4%로 성장할 것으로 예상됩니다. 통신 기술 발전, 정부의 우호적인 지원 및 규제 정책, 그리고 정기적인 의료 기록 관리(RPM) 시스템 확대 등 다양한 요인으로 인해 원격 진료 및 원격 의료 AI 시장은 빠르게 성장하고 있습니다. 고령 인구 증가로 만성 질환에 대한 지속적인 모니터링이 필요해지면서 비용 효율적인 의료 솔루션에 대한 수요가 증가하고 있습니다. 당뇨병이나 심장 질환과 같은 만성 질환 진단에 대한 관심이 높아짐에 따라 원격 진료 기기에 대한 수요도 증가하고 있습니다. 가상 비서, 예측 분석, 자동 메모 작성과 같은 AI 기술은 원격 진료 서비스의 효과와 가용성을 향상시키는 데 도움이 됩니다. 예를 들어, 2025년 3월, 일라이 릴리(미국)는 알츠하이머병 진단 및 치료를 위한 원격 진료 서비스인 릴리다이렉트(LillyDirect)를 출시했습니다. 원격 진료 기기는 전문의 부족 및 환자 대기 시간 등의 문제를 해결하여 의료 서비스 개선과 환자의 첨단 의료 솔루션 접근성을 향상시킵니다.
The software segment is expected to have the fastest growth rate in the AI in telehealth market during the forecast period, by component.
By component, the software segment is expected to be the fastest growing market during the forecast period. Companies have promoted telehealth software due to the need for less capital for infrastructural development. Advanced software platforms enhanced with AI and ML have predictive analytics, personalization, and tailored care strategies, which also help companies promote telehealth solutions. Companies such as Cisco Systems, Inc. (US) offer Cisco HealthPresence 2.5 software solutions. Additionally, in February 2025, Teladoc Health Inc. (US) acquired Catapult Health (US), a provider of virtual preventive care solutions, for USD 65 million; this acquisition supports Teladoc Health Inc. in strengthening its market position.
The healthcare providers segment accounted for the largest market share in 2023.
On the basis of end users, the healthcare providers segment accounted for the largest market share in 2023. RPM, AI, and cloud systems allow for the personalization and timely delivery of healthcare services, which helps manage the increasing adoption of remote consultations and chronic disease management. Many healthcare facilities have adopted the telehealth platform to reduce waiting periods and can handle large patient pools with less administrative workflow. For instance, Mercy Health (US) offers Mercy Virtual Care Services, serving over 600,000 patients across seven US states with more than 300 clinicians, delivering care through advanced technologies such as two-way video, online-enabled instruments, and real-time vital sign monitoring. The program enhances patient access and outcomes while reducing healthcare costs by enabling earlier interventions and continuous remote monitoring for those with chronic or complex conditions.
The Asia Pacific is estimated to register the fastest CAGR during the forecast period.
The AI in telemedicine market is geographically segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is projected to register the fastest CAGR during the forecast period as it benefits from the fast-developing healthcare infrastructure and technological advancements. In addition, the rising use of digital healthcare products, growing healthcare needs resulting from large geriatric populations, and an increasing incidence of chronic diseases drive regional growth. Government initiatives also promote market growth. In February 2024, South Korea’s health ministry announced it would fully allow telemedicine services at all hospitals and clinics. In addition, India offers universal health coverage through the national telemedicine service (eSanjeevani), which covers 130 specialties. The platform has created 17,084 telemedicine hubs and serviced 364,497,645 patients to date. Government initiatives promoting telemedicine and improvements in digital health infrastructure also contributed to market growth.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
- By Designation: Managers (40%), Directors (35%), and Other Designations (25%)
- By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and Middle East & Africa (2%)
List of Companies Profiled in the Report:
- Koninklijke Philips N.V. (Netherlands)
- Medtronic (Ireland)
- GE Healthcare (US)
- Epic Systems Corporation (US)
- Oracle (US)
- Doximity, Inc. (US)
- Teladoc Health, Inc. (US)
- American Well (US)
- Siemens Healthineers AG (Germany)
- Cisco Systems Inc. (US)
- Included Health, Inc. (US)
- AMC Health (US)
- TeleSpecialists (US)
- Walgreen Co. (US)
- Caregility (US)
- CVS Health (US)
- AliveCor, Inc. (US)
- Elation (US)
- HealthTap, Inc. (US)
- ZoomCommunications, Inc. (US)
Research Coverage:
This research report categorizes the AI in telehealth & telemedicine market by component [hardware, software {(by modality: EHR-centric, Non-EHR-centric), (by integration type: integrated software, standalone software), (by deployment: on-premise deployment, cloud-based deployment)}, and services], by function [virtual care consultations, chatbots & virtual assistants, remote patient monitoring, virtual nursing care platform, clinical documentation, administrative workflows, analytics & reporting, patient engagement, and other functions[, by application [primary care, speciality care {teleradiology, telecardiology, teleneurology, diabetes, respiratory disorders, hypertension, teledermatology, telepsychiatry, other specialty care applications}, teleICU, and other applications], by end user [healthcare providers {hospitals; ambulatory surgery centers, ambulatory care centers, and other outpatient settings; long-term care & assisted living facilities; home healthcare; and other healthcare providers}, healthcare payers, patients, pharmaceutical & biotechnology companies, medtech companies, and other end users], and region. The report’s scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the AI in telehealth & telemedicine market. A thorough analysis of the key industry players has provided insights into their business overview, offerings, and key strategies, such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals in the AI in telehealth & telemedicine market. This report covers the competitive analysis of upcoming startups in the AI in telehealth & telemedicine market ecosystem.
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall AI in telehealth and telemedicine market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers: (increasing adoption of virtual assistant chatbots, rising popularity of e-prescriptions, growing adoption of EHRs in healthcare settings, advancements in digital health technologies, and shortage of skilled healthcare professionals), restraints (Regulatory variations across regions and lack of advanced telemedicine infrastructure in emerging economies), opportunities (growing popularity of virtual healthcare solutions, emergence of AI and ML, favorable government initiatives and reimbursement policies, rising focus on home healthcare, and expansion of remote patient monitoring markets), and challenges (Increasing data breaches and medical identity theft cases and complexities of big data in healthcare) influencing the growth of the AI in telehealth & telemedicine market.
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product & service launches in the AI in telehealth & telemedicine market.
- Market Development: Comprehensive information about lucrative markets—the report analyses the AI in telehealth & telemedicine market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the AI in telehealth & telemedicine market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), and Teladoc Health, Inc. (US), among others
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 TELEHEALTH 35
1.2.2 TELEMEDICINE 35
1.3 STUDY SCOPE 36
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 36
1.3.2 INCLUSIONS & EXCLUSIONS 37
1.3.3 YEARS CONSIDERED 38
1.3.4 CURRENCY CONSIDERED 39
1.4 STAKEHOLDERS 39
2 RESEARCH METHODOLOGY 41
2.1 RESEARCH DATA 41
2.1.1 SECONDARY DATA 42
2.1.1.1 Key sources for secondary data 42
2.1.1.2 Key data from secondary sources 43
2.1.2 PRIMARY DATA 43
2.1.2.1 Key sources for primary data 44
2.1.2.2 Key objectives of primary research 44
2.1.2.3 Key data from primary sources 45
2.1.2.4 Insights from primary experts 46
2.2 MARKET SIZE ESTIMATION 47
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 47
2.2.2 TOP-DOWN APPROACH 48
2.3 DATA TRIANGULATION 52
2.4 MARKET SHARE ESTIMATION 53
2.5 STUDY ASSUMPTIONS 53
2.6 RESEARCH LIMITATIONS 53
2.6.1 METHODOLOGY-RELATED LIMITATIONS 53
2.6.2 SCOPE-RELATED LIMITATIONS 54
2.7 RISK ANALYSIS 54
3 EXECUTIVE SUMMARY 55
4 PREMIUM INSIGHTS 60
4.1 AI IN TELEHEALTH & TELEMEDICINE MARKET OVERVIEW 60
4.2 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT AND COUNTRY 61
4.3 AI IN TELEHEALTH & TELEMEDICINE MARKET: GEOGRAPHIC SNAPSHOT 62
4.4 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEVELOPED VS. EMERGING MARKETS 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
5.2.1 DRIVERS 65
5.2.1.1 Increasing adoption of virtual assistant chatbots 65
5.2.1.2 Rising popularity of e-prescriptions 66
5.2.1.3 Growing adoption of EHRs in healthcare settings 66
5.2.1.4 Advancements in digital health technologies 67
5.2.1.5 Shortage of skilled healthcare professionals 68
5.2.2 RESTRAINTS 68
5.2.2.1 Regulatory variations across regions 68
5.2.2.2 Lack of advanced telemedicine infrastructure in emerging economies 69
5.2.3 OPPORTUNITIES 69
5.2.3.1 Growing popularity of virtual healthcare solutions 69
5.2.3.2 Emergence of AI and ML 69
5.2.3.3 Favorable government initiatives and reimbursement policies 70
5.2.3.4 Rising focus on home healthcare 70
5.2.3.5 Expansion of remote patient monitoring markets 71
5.2.4 CHALLENGES 72
5.2.4.1 Increasing data breaches and medical identity theft cases 72
5.2.4.2 Complexities of big data in healthcare 75
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 75
5.4 INDUSTRY TRENDS 76
5.4.1 GEN AI FOR MEDICAL DOCUMENTATION 76
5.4.2 INNOVATIONS IN REMOTE PATIENT MONITORING DEVICES 76
5.5 ECOSYSTEM ANALYSIS 76
5.5.1 ROLE IN ECOSYSTEM 78
5.6 VALUE CHAIN ANALYSIS 79
5.7 TECHNOLOGY ANALYSIS 80
5.7.1 KEY TECHNOLOGIES 80
5.7.1.1 Video conferencing and real-time communication platforms 80
5.7.1.2 Virtual assistants and chatbots 80
5.7.1.3 Voice recognition and natural language processing 80
5.7.1.4 EHR integration 81
5.7.1.5 Remote patient monitoring systems 81
5.7.2 COMPLEMENTARY TECHNOLOGIES 81
5.7.2.1 Cloud computing 81
5.7.2.2 mHealth applications 81
5.7.2.3 Wearable devices, sensors, and IoT 82
5.7.3 ADJACENT TECHNOLOGIES 82
5.7.3.1 Digital therapeutics 82
5.7.3.2 Blockchain technologies 82
5.7.3.3 Augmented reality and virtual reality 82
5.8 TARIFF & REGULATORY ANALYSIS 83
5.8.1 TARIFF DATA ANALYSIS 83
5.8.1.1 Average tariff for HS code 9018 83
5.8.1.2 Average tariff for HS code 9021 84
5.8.1.3 Average tariff for HS code 9022 85
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
5.8.3 REGULATORY STANDARDS 89
5.8.4 REGULATORY REQUIREMENTS 90
5.9 TRADE ANALYSIS 92
5.9.1 TRADE ANALYSIS FOR HSN CODE 90189099, 2019–2023 93
5.9.1.1 Top 10 importers for HSN code 90189099 93
5.9.1.2 Top 10 exporters for HSN code 90189099 93
5.9.2 TRADE ANALYSIS FOR HSN CODE 9021, 2019–2023 94
5.9.2.1 Top 10 importers for HSN code 9021 94
5.9.2.2 Top 10 exporters for HSN code 9021 94
5.9.3 TRADE ANALYSIS FOR HSN CODE 9022, 2019–2023 95
5.9.3.1 Top 10 importers for HSN code 9022 95
5.9.3.2 Top 10 exporters for HSN code 9022 95
5.10 PRICING ANALYSIS 96
5.10.1 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY COMPONENT, 2023 97
5.10.2 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022–2024 98
5.10.3 PRICING MODELS 99
5.11 PORTER’S FIVE FORCES ANALYSIS 99
5.11.1 INTENSITY OF COMPETITIVE RIVALRY 101
5.11.2 THREAT OF NEW ENTRANTS 101
5.11.3 THREAT OF SUBSTITUTES 101
5.11.4 BARGAINING POWER OF BUYERS 101
5.11.5 BARGAINING POWER OF SUPPLIERS 102
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 102
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 102
5.12.2 KEY BUYING CRITERIA 103
5.13 PATENT ANALYSIS 104
5.13.1 PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 104
5.13.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 105
5.14 UNMET NEEDS & END-USER EXPECTATIONS 106
5.14.1 UNMET NEEDS 106
5.14.2 END-USER EXPECTATIONS 107
5.15 KEY CONFERENCES & EVENTS, 2025–2026 108
5.16 CASE STUDY ANALYSIS 110
5.16.1 TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION 110
5.16.2 TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS 110
5.16.3 LMH HEALTH TO REDUCE NURSE WORKLOAD WITH VIRTUAL NURSING 111
5.17 INVESTMENT & FUNDING SCENARIO 111
5.18 BUSINESS MODEL ANALYSIS 112
5.18.1 DIRECT-TO-PATIENT (D2P) MODELS 112
5.18.2 BUSINESS-TO-BUSINESS (B2B) MODELS 112
5.18.3 EMPLOYER-SPONSORED MODELS 112
5.18.4 SUBSCRIPTION-BASED MODELS 112
5.18.5 HYBRID TELEMEDICINE MODELS 112
5.18.6 PLATFORM-AS-A-SERVICE (PAAS) MODELS 113
5.18.7 VALUE-BASED CARE MODELS 113
5.19 REIMBURSEMENT SCENARIO ANALYSIS 113
6 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT 116
6.1 INTRODUCTION 117
6.2 HARDWARE 117
6.2.1 HIGH DEMAND FOR REMOTE PATIENT MONITORING DEVICES TO SPUR MARKET GROWTH 117
6.3 SOFTWARE 119
6.3.1 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY 120
6.3.1.1 EHR-centric software 120
6.3.1.1.1 EHR-centric software to facilitate better care coordination and streamline administrative tasks 120
6.3.1.2 Non-EHR-centric software 121
6.3.1.2.1 Non-EHR-centric software to conduct virtual consultations and facilitate remote telehealth services 121
6.3.2 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE 122
6.3.2.1 Integrated software 123
6.3.2.1.1 Better accessibility and efficiency in integrated software to revolutionize patient care 123
6.3.2.2 Standalone software 124
6.3.2.2.1 Flexibility and ease of usage to fuel uptake for high-quality remote patient care 124
6.3.3 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT 125
6.3.3.1 On-premises deployment 126
6.3.3.1.1 On-premises deployment to enhance safety and control of inventory data 126
6.3.3.2 Cloud-based deployment 127
6.3.3.2.1 Cost-effectiveness and easy optimization of complex IT systems to boost market growth 127
6.4 SERVICES 128
6.4.1 TELEHEALTH SERVICES TO REDUCE IN-PERSON CLINIC VISITS AND ENSURE BETTER TREATMENT ACCESSIBILITY FOR REMOTE AREAS 128
7 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION 130
7.1 INTRODUCTION 131
7.2 VIRTUAL CARE CONSULTATION 131
7.2.1 AI-BASED VIRTUAL CARE PLANS TO AUTOMATE DOCUMENTATION AND OFFER BETTER CLINICAL DECISION SUPPORT 131
7.3 CHATBOTS & VIRTUAL ASSISTANTS 132
7.3.1 CHATBOTS & VIRTUAL ASSISTANTS TO ENHANCE PATIENT ENGAGEMENT AND PROVIDE REAL-TIME HEALTH SUPPORT 132
7.4 REMOTE PATIENT MONITORING 133
7.4.1 EFFECTIVE REAL-TIME DISEASE MONITORING WITHOUT IN-PATIENT VISITS TO DRIVE MARKET 133
7.5 VIRTUAL NURSING CARE PLATFORMS 134
7.5.1 VIRTUAL NURSING PLATFORMS TO ELIMINATE NURSING SHORTAGES, REDUCE BURNOUT, AND PROVIDE HIGH-QUALITY CARE 134
7.6 CLINICAL DOCUMENTATION 135
7.6.1 NEED FOR ACCURATE AND COMPLIANT MEDICAL RECORDS FOR VIRTUAL CONSULTATIONS TO AUGMENT MARKET GROWTH 135
7.7 ADMINISTRATIVE WORKFLOW 136
7.7.1 EFFECTIVE RESOURCE MANAGEMENT AND OPERATIONAL EFFICIENCY TO AID MARKET GROWTH 136
7.8 ANALYTICS & REPORTING 137
7.8.1 ADVANCED ANALYTICS & REPORTING TOOLS TO FOSTER BETTER CARE COORDINATION AND PROVIDE PERSONALIZED TREATMENTS 137
7.9 PATIENT ENGAGEMENT 138
7.9.1 BETTER PATIENT ENGAGEMENT TO ADVANCE HEALTHCARE DELIVERY AND PROMOTE BETTER ADHERENCE TO TREATMENT PLANS 138
7.10 OTHER FUNCTIONS 139
8 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION 141
8.1 INTRODUCTION 142
8.2 PRIMARY CARE APPLICATIONS 142
8.2.1 TECHNOLOGICAL ADVANCEMENTS AND DEMAND FOR PERSONALIZED HEALTHCARE DELIVERY TO PROPEL MARKET GROWTH 142
8.3 SPECIALTY CARE APPLICATIONS 143
8.3.1 TELERADIOLOGY 145
8.3.1.1 Reduced turnaround time for imaging reports and better access to radiologists in remote areas to support market growth 145
8.3.2 TELECARDIOLOGY 146
8.3.2.1 Real-time ECG interpretations and remote cardiac care for chronic patients to augment market growth 146
8.3.3 TELENEUROLOGY 146
8.3.3.1 Growing focus on advanced neurological care without in-person visits to aid market growth 146
8.3.4 DIABETES 147
8.3.4.1 Rising prevalence of diabetes to drive market 147
8.3.5 RESPIRATORY DISORDERS 148
8.3.5.1 Increasing incidence of respiratory diseases among geriatric population to propel market growth 148
8.3.6 HYPERTENSION 149
8.3.6.1 Need for constant monitoring and high prevalence of hypertension to boost market growth 149
8.3.7 TELEDERMATOLOGY 150
8.3.7.1 Increased occurrence of skin cancer to fuel market growth 150
8.3.8 TELEPSYCHIATRY 150
8.3.8.1 Shortage of mental health practitioners in rural areas to fuel uptake 150
8.3.9 OTHER SPECIALTY CARE APPLICATIONS 151
8.4 TELEICU 152
8.4.1 INCREASE IN EMERGENCY DEPARTMENT VISITS AND UNEVEN DISTRIBUTION OF ER SPECIALISTS TO PROPEL MARKET GROWTH 152
8.5 OTHER APPLICATIONS 152
9 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER 154
9.1 INTRODUCTION 155
9.2 HEALTHCARE PROVIDERS 155
9.2.1 HOSPITALS 157
9.2.1.1 Growing incidence of chronic diseases and increasing demand for high-quality care to aid market growth 157
9.2.2 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS 158
9.2.2.1 Cost-effectiveness and reduced patient downtime to augment market growth 158
9.2.3 LONG-TERM CARE & ASSISTED LIVING FACILITIES 159
9.2.3.1 Need for prolonged treatment for chronic diseases to support market growth 159
9.2.4 HOME HEALTHCARE 160
9.2.4.1 Demand for cost-effective solutions and low hospital readmissions to propel segment growth 160
9.2.5 OTHER HEALTHCARE PROVIDERS 160
9.3 HEALTHCARE PAYERS 161
9.3.1 HEALTHCARE PAYERS TO REDUCE OVERHEAD COSTS, MINIMIZE PAPER TRAILS, AND IMPROVE MEMBER SERVICES 161
9.4 PATIENTS 162
9.4.1 EMERGENCE OF ADVANCED WEARABLE DEVICES AND USE OF AI IN PERSONALIZED PATIENT CARE TO FUEL MARKET GROWTH 162
9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 163
9.5.1 NEED FOR STREAMLINED DRUG DEVELOPMENT PROCESSES AND ENHANCED CLINICAL TRIAL PARTICIPATION TO DRIVE MARKET 163
9.6 MEDTECH COMPANIES 164
9.6.1 MEDTECH COMPANIES TO IMPROVE DIAGNOSTIC ACCURACY AND FACILITATE PERSONALIZED TREATMENT PLANS 164
9.7 OTHER END USERS 165
10 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION 167
10.1 INTRODUCTION 168
10.2 NORTH AMERICA 168
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 168
10.2.2 US 174
10.2.2.1 US to dominate North American market during forecast period 174
10.2.3 CANADA 179
10.2.3.1 Government initiatives on digital health integration to drive adoption of telehealth and mHealth applications 179
10.3 EUROPE 183
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 183
10.3.2 GERMANY 188
10.3.2.1 Favorable government initiatives to support market growth 188
10.3.3 UK 193
10.3.3.1 Growing reliance on digital healthcare platforms and increasing investments in remote mental health services to drive market 193
10.3.4 FRANCE 197
10.3.4.1 Favorable reimbursement for telemedicine solutions to spur market growth 197
10.3.5 ITALY 202
10.3.5.1 Strategic government regulations and high investments in healthcare digitalization to augment market growth 202
10.3.6 SPAIN 206
10.3.6.1 Rapid expansion of eHealth sector and increased adoption of wearable technologies to favor market growth 206
10.3.7 REST OF EUROPE 211
10.4 ASIA PACIFIC 215
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 221
10.4.2 CHINA 221
10.4.2.1 Increasing private sector investments in digital infrastructure to boost market growth 221
10.4.3 JAPAN 226
10.4.3.1 High geriatric population and strong technological infrastructure to propel market growth 226
10.4.4 INDIA 230
10.4.4.1 Increased government focus on digital transformation in rural areas to aid market growth 230
10.4.5 REST OF ASIA PACIFIC 235
10.5 LATIN AMERICA 239
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 240
10.5.2 BRAZIL 244
10.5.2.1 Increasing adoption of digital health solutions in public and private systems to aid market growth 244
10.5.3 MEXICO 249
10.5.3.1 Favorable regulatory scenario to fuel market growth 249
10.5.4 REST OF LATIN AMERICA 254
10.6 MIDDLE EAST & AFRICA 258
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 258
10.6.2 GCC COUNTRIES 263
10.6.2.1 Shortage of skilled healthcare workforce to support market growth 263
10.6.3 REST OF MIDDLE EAST & AFRICA 268
11 COMPETITIVE LANDSCAPE 273
11.1 INTRODUCTION 273
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 273
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET 273
11.3 REVENUE ANALYSIS, 2020–2024 276
11.4 MARKET SHARE ANALYSIS, 2023 277
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 279
11.5.1 STARS 279
11.5.2 EMERGING LEADERS 279
11.5.3 PERVASIVE PLAYERS 280
11.5.4 PARTICIPANTS 280
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 281
11.5.5.1 Company footprint 281
11.5.5.2 Region footprint 282
11.5.5.3 Function footprint 283
11.5.5.4 Application footprint 284
11.5.5.5 Component footprint 285
11.5.5.6 End-user footprint 286
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 287
11.6.1 PROGRESSIVE COMPANIES 287
11.6.2 RESPONSIVE COMPANIES 287
11.6.3 DYNAMIC COMPANIES 287
11.6.4 STARTING BLOCKS 287
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 289
11.6.5.1 Detailed list of key startups/SMEs 289
11.6.5.2 Competitive benchmarking of key startups/SMEs, by region 289
11.7 COMPANY VALUATION & FINANCIAL METRICS 290
11.7.1 FINANCIAL METRICS 290
11.7.2 COMPANY VALUATION 290
11.8 BRAND/SOFTWARE COMPARISON 291
11.9 COMPETITIVE SCENARIO 292
11.9.1 PRODUCT LAUNCHES & APPROVALS 292
11.9.2 DEALS 293
12 COMPANY PROFILE 294
12.1 KEY PLAYERS 294
12.1.1 MEDTRONIC 294
12.1.1.1 Business overview 294
12.1.1.2 Products/Services/Solutions offered 296
12.1.1.3 Recent developments 297
12.1.1.3.1 Product launches and approvals 297
12.1.1.3.2 Deals 298
12.1.1.4 MnM view 299
12.1.1.4.1 Right to win 299
12.1.1.4.2 Strategic choices 299
12.1.1.4.3 Weaknesses & competitive threats 299
12.1.2 TELADOC HEALTH, INC. 300
12.1.2.1 Business overview 300
12.1.2.2 Products/Services/Solutions offered 302
12.1.2.3 Recent developments 303
12.1.2.3.1 Product launches and upgrades 303
12.1.2.3.2 Deals 304
12.1.2.4 MnM view 305
12.1.2.4.1 Right to win 305
12.1.2.4.2 Strategic choices 305
12.1.2.4.3 Weaknesses & competitive threats 305
12.1.3 KONINKLIJKE PHILIPS N.V. 306
12.1.3.1 Business overview 306
12.1.3.2 Products/Services/Solutions offered 307
12.1.3.3 Recent developments 309
12.1.3.3.1 Product approvals 309
12.1.3.3.2 Deals 309
12.1.3.4 MnM view 310
12.1.3.4.1 Right to win 310
12.1.3.4.2 Strategic choices 310
12.1.3.4.3 Weaknesses & competitive threats 310
12.1.4 CISCO SYSTEMS, INC. 311
12.1.4.1 Business overview 311
12.1.4.2 Products/Services/Solutions offered 313
12.1.4.3 Recent developments 314
12.1.4.3.1 Product launches 314
12.1.4.3.2 Deals 314
12.1.4.4 MnM view 314
12.1.4.4.1 Right to win 314
12.1.4.4.2 Strategic choices 315
12.1.4.4.3 Weaknesses & competitive threats 315
12.1.5 GE HEALTHCARE 316
12.1.5.1 Business overview 316
12.1.5.2 Products/Services/Solutions offered 318
12.1.5.3 Recent developments 319
12.1.5.3.1 Product launches and approvals 319
12.1.5.3.2 Deals 319
12.1.5.4 MnM view 320
12.1.5.4.1 Right to win 320
12.1.5.4.2 Strategic choices 320
12.1.5.4.3 Weaknesses & competitive threats 320
12.1.6 EPIC SYSTEMS CORPORATION 321
12.1.6.1 Business overview 321
12.1.6.2 Products/Services/Solutions offered 322
12.1.6.3 Recent developments 323
12.1.6.3.1 Product launches and upgrades 323
12.1.6.3.2 Deals 324
12.1.7 ORACLE 325
12.1.7.1 Business overview 325
12.1.7.2 Products/Services/Solutions offered 327
12.1.7.3 Recent developments 328
12.1.7.3.1 Product launches 328
12.1.7.3.2 Deals 329
12.1.8 DOXIMITY, INC. 331
12.1.8.1 Business overview 331
12.1.8.2 Products/Services/Solutions offered 332
12.1.8.3 Recent developments 333
12.1.8.3.1 Product upgrades 333
12.1.8.3.2 Deals 333
12.1.8.3.3 Other developments 334
12.1.9 INCLUDED HEALTH, INC. 335
12.1.9.1 Business overview 335
12.1.9.2 Products/Services/Solutions offered 335
12.1.9.3 Recent developments 336
12.1.9.3.1 Deals 336
12.1.9.3.2 Other developments 337
12.1.10 ZOOM COMMUNICATIONS, INC. 338
12.1.10.1 Business overview 338
12.1.10.2 Products/Services/Solutions offered 339
12.1.10.3 Recent developments 340
12.1.10.3.1 Deals 340
12.1.11 AMERICAN WELL 341
12.1.11.1 Business overview 341
12.1.11.2 Products/Services/Solutions offered 342
12.1.11.3 Recent developments 343
12.1.11.3.1 Product launches 343
12.1.11.3.2 Deals 344
12.1.11.3.3 Other developments 344
12.1.12 SIEMENS HEALTHINEERS AG 345
12.1.12.1 Business overview 345
12.1.12.2 Products/Services/Solutions offered 346
12.1.12.3 Recent developments 347
12.1.12.3.1 Product approvals 347
12.1.13 AMC HEALTH 348
12.1.13.1 Business overview 348
12.1.13.2 Products/Services/Solutions offered 348
12.1.13.3 Recent developments 349
12.1.13.3.1 Deals 349
12.1.14 TELESPECIALISTS 350
12.1.14.1 Business overview 350
12.1.14.2 Products/Services/Solutions offered 350
12.1.14.3 Recent developments 351
12.1.14.3.1 Product launches 351
12.1.14.3.2 Deals 351
12.1.14.3.3 Other developments 352
12.1.15 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.) 353
12.1.15.1 Business overview 353
12.1.15.2 Products/Services/Solutions offered 354
12.1.15.3 Recent developments 355
12.1.15.3.1 Product launches 355
12.1.15.3.2 Expansions 355
12.1.16 CAREGILITY 356
12.1.16.1 Business overview 356
12.1.16.2 Products/Services/Solutions offered 356
12.1.16.3 Recent developments 357
12.1.16.3.1 Product launches and upgrades 357
12.1.16.3.2 Deals 357
12.1.16.3.3 Other developments 358
12.1.17 CVS HEALTH 359
12.1.17.1 Business overview 359
12.1.17.2 Products/Services/Solutions offered 360
12.1.17.3 Recent developments 361
12.1.17.3.1 Product launches and upgrades 361
12.1.18 ALIVECOR, INC. 362
12.1.18.1 Business overview 362
12.1.18.2 Products/Services/Solutions offered 362
12.1.18.3 Recent developments 363
12.1.18.3.1 Product launches and approvals 363
12.1.18.3.2 Deals 364
12.1.18.3.3 Other developments 365
12.1.19 ELATION 366
12.1.19.1 Business overview 366
12.1.19.2 Products/Services/Solutions offered 366
12.1.19.3 Recent developments 367
12.1.19.3.1 Deals 367
12.1.20 HEALTHTAP, INC. 368
12.1.20.1 Business overview 368
12.1.20.2 Products/Services/Solutions offered 368
12.1.20.3 Recent developments 369
12.1.20.3.1 Product launches 369
12.1.20.3.2 Deals 369
12.2 OTHER PLAYERS 370
12.2.1 CURAI HEALTH 370
12.2.2 ANDOR HEALTH 371
12.2.3 K HEALTH 372
12.2.4 TRANSCARENT 373
12.2.5 BIOINTELLISENSE, INC. 374
13 APPENDIX 375
13.1 DISCUSSION GUIDE 375
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 381
13.3 CUSTOMIZATION OPTIONS 383
13.4 RELATED REPORTS 383
13.5 AUTHOR DETAILS 384
LIST OF TABLES
TABLE 1 AI IN TELEHEALTH & TELEMEDICINE MARKET: INCLUSIONS & EXCLUSIONS 37
TABLE 2 AI IN TELEHEALTH & TELEMEDICINE MARKET: STUDY ASSUMPTIONS 53
TABLE 3 AI IN TELEHEALTH & TELEMEDICINE MARKET: RISK ANALYSIS 54
TABLE 4 MARKET DYNAMICS: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
TABLE 5 RECENT DEVELOPMENTS FOR REMOTE PATIENT MONITORING SYSTEMS 72
TABLE 6 TOP 30 HEALTHCARE DATA BREACHES IN US, 2011−2024 74
TABLE 7 AI IN TELEHEALTH & TELEMEDICINE MARKET: ROLE IN ECOSYSTEM 78
TABLE 8 AVERAGE TARIFF FOR HS CODE 9018 IN 2023 83
TABLE 9 AVERAGE TARIFF FOR HS CODE 9021 IN 2023 84
TABLE 10 AVERAGE TARIFF FOR HS CODE 9022 IN 2023 85
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 86
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 14 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGULATORY STANDARDS 89
TABLE 15 REGULATORY REQUIREMENTS IN NORTH AMERICA 90
TABLE 16 REGULATORY REQUIREMENTS IN EUROPE 91
TABLE 17 REGULATORY REQUIREMENTS IN ASIA PACIFIC 91
TABLE 18 REGULATORY REQUIREMENTS IN LATIN AMERICA 92
TABLE 19 REGULATORY REQUIREMENTS IN MIDDLE EAST & AFRICA 92
TABLE 20 TOP 10 IMPORTERS FOR HSN CODE 90189099, BY COUNTRY,
2019–2023 (USD THOUSAND) 93
TABLE 21 TOP 10 EXPORTERS FOR HSN CODE 90189099, BY COUNTRY,
2019–2023 (USD THOUSAND) 93
TABLE 22 TOP 10 IMPORTERS FOR HSN CODE 9021, BY COUNTRY,
2019–2023 (USD THOUSAND) 94
TABLE 23 TOP 10 EXPORTERS FOR HSN CODE 9021, BY COUNTRY,
2019–2023 (USD THOUSAND) 94
TABLE 24 TOP 10 IMPORTERS FOR HSN CODE 9022, BY COUNTRY,
2019–2023 (USD THOUSAND) 95
TABLE 25 TOP 10 EXPORTERS FOR HSN CODE 9022, BY COUNTRY,
2019–2023 (USD THOUSAND) 95
TABLE 26 COST RANGE INVOLVED IN AI-BASED TELEHEALTH & TELEMEDICINE
DEVICES (USD) 96
TABLE 27 INDICATIVE PRICE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES,
BY COMPONENT, 2023 97
TABLE 28 AVERAGE SELLING PRICE OF TELADOC CONSULTATIONS 97
TABLE 29 AVERAGE PRICING TREND OF AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, BY REGION, 2022–2024 (USD) 98
TABLE 30 AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES 101
TABLE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP
FOUR END USERS 103
TABLE 32 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 103
TABLE 33 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 105
TABLE 34 AI IN TELEHEALTH & TELEMEDICINE MARKET: UNMET NEEDS 107
TABLE 35 AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER EXPECTATIONS 107
TABLE 36 AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 108
TABLE 37 CASE STUDY 1: TRANSFORMING PATIENT CARE AND OPERATIONAL EFFICIENCY WITH CAREGILITY VIRTUAL NURSING SOLUTION 110
TABLE 38 CASE STUDY 2: TELADOC HEALTH TO PROVIDE MEDICARE ADVANTAGE
PLAN FOR CLOSING GAPS AND BOOSTING QUALITY RATINGS 110
TABLE 39 CASE STUDY 3: LMH HEALTH TO REDUCE NURSE WORKLOAD WITH
VIRTUAL NURSING 111
TABLE 40 AI IN TELEHEALTH & TELEMEDICINE MARKET: CPT CODES AND
REIMBURSEMENT ANALYSIS 114
TABLE 41 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 117
TABLE 42 MAJOR COMPANIES OFFERING HARDWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 118
TABLE 43 AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION,
2022–2030 (USD MILLION) 118
TABLE 44 AI IN TELEHEALTH & TELEMEDICINE HARDWARE MARKET, BY REGION,
2022–2030 (THOUSAND UNITS) 118
TABLE 45 MAJOR COMPANIES OFFERING SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 119
TABLE 46 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY REGION,
2022–2030 (USD MILLION) 119
TABLE 47 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY,
2022–2030 (USD MILLION) 120
TABLE 48 MAJOR COMPANIES OFFERING EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 121
TABLE 49 EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 121
TABLE 50 MAJOR COMPANIES OFFERING NON-EHR-CENTRIC SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 122
TABLE 51 NON-EHR-CENTRIC SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 122
TABLE 52 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 123
TABLE 53 MAJOR COMPANIES OFFERING INTEGRATED SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 123
TABLE 54 INTEGRATED SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 124
TABLE 55 MAJOR COMPANIES OFFERING STANDALONE SOFTWARE FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 124
TABLE 56 STANDALONE SOFTWARE MARKET, BY REGION, 2022–2030 (USD MILLION) 125
TABLE 57 AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 125
TABLE 58 ON-PREMISES DEPLOYMENT MARKET, BY REGION, 2022–2030 (USD MILLION) 126
TABLE 59 MAJOR COMPANIES OFFERING CLOUD-BASED DEPLOYMENT FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 127
TABLE 60 CLOUD-BASED DEPLOYMENT MARKET, BY REGION, 2022–2030 (USD MILLION) 128
TABLE 61 MAJOR COMPANIES OFFERING AI-BASED TELEHEALTH & TELEMEDICINE SERVICES 128
TABLE 62 AI IN TELEHEALTH & TELEMEDICINE SERVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 129
TABLE 63 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 131
TABLE 64 MAJOR COMPANIES OFFERING VIRTUAL CARE CONSULTATIONS 132
TABLE 65 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL CARE CONSULTATION, BY REGION, 2022–2030 (USD MILLION) 132
TABLE 66 MAJOR COMPANIES OFFERING CHATBOTS & VIRTUAL ASSISTANTS 133
TABLE 67 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CHATBOTS & VIRTUAL ASSISTANTS, BY REGION, 2022–2030 (USD MILLION) 133
TABLE 68 MAJOR COMPANIES OFFERING REMOTE PATIENT MONITORING 134
TABLE 69 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR REMOTE PATIENT MONITORING, BY REGION, 2022–2030 (USD MILLION) 134
TABLE 70 MAJOR COMPANIES OFFERING VIRTUAL NURSING CARE 135
TABLE 71 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR VIRTUAL NURSING CARE PLATFORMS, BY REGION, 2022–2030 (USD MILLION) 135
TABLE 72 MAJOR COMPANIES OFFERING CLINICAL DOCUMENTATION 136
TABLE 73 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR CLINICAL DOCUMENTATION,
BY REGION, 2022–2030 (USD MILLION) 136
TABLE 74 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ADMINISTRATIVE WORKFLOW, BY REGION, 2022–2030 (USD MILLION) 137
TABLE 75 MAJOR COMPANIES OFFERING ANALYTICS & REPORTING 137
TABLE 76 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR ANALYTICS & REPORTING,
BY REGION, 2022–2030 (USD MILLION) 138
TABLE 77 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENT ENGAGEMENT,
BY REGION, 2022–2030 (USD MILLION) 139
TABLE 78 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER FUNCTIONS, BY REGION, 2022–2030 (USD MILLION) 140
TABLE 79 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 142
TABLE 80 MAJOR COMPANIES OFFERING PRIMARY CARE APPLICATIONS 143
TABLE 81 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PRIMARY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 143
TABLE 82 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 144
TABLE 83 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY REGION, 2022–2030 (USD MILLION) 144
TABLE 84 TELERADIOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 145
TABLE 85 TELECARDIOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 146
TABLE 86 TELENEUROLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 147
TABLE 87 MAJOR COMPANIES OFFERING SOLUTIONS FOR DIABETES 147
TABLE 88 DIABETES MARKET, BY REGION 2022–2030 (USD MILLION) 148
TABLE 89 MAJOR COMPANIES OFFERING SOLUTIONS FOR RESPIRATORY DISORDERS 148
TABLE 90 RESPIRATORY DISORDERS MARKET, BY REGION, 2022–2030 (USD MILLION) 149
TABLE 91 HYPERTENSION MARKET, BY REGION, 2022–2030 (USD MILLION) 149
TABLE 92 TELEDERMATOLOGY MARKET, BY REGION, 2022–2030 (USD MILLION) 150
TABLE 93 TELEPSYCHIATRY MARKET, BY REGION, 2022–2030 (USD MILLION) 151
TABLE 94 OTHER SPECIALTY CARE APPLICATIONS MARKET, BY REGION,
2022–2030 (USD MILLION) 151
TABLE 95 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR TELEICU, BY REGION,
2022–2030 (USD MILLION) 152
TABLE 96 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER APPLICATIONS,
BY REGION, 2022–2030 (USD MILLION) 153
TABLE 97 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 155
TABLE 98 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY TYPE, 2022–2030 (USD MILLION) 156
TABLE 99 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS,
BY REGION, 2022–2030 (USD MILLION) 156
TABLE 100 HOSPITALS MARKET, BY REGION, 2022–2030 (USD MILLION) 157
TABLE 101 AMBULATORY SURGERY CENTERS, AMBULATORY CARE CENTERS, AND OTHER OUTPATIENT SETTINGS MARKET, BY REGION, 2022–2030 (USD MILLION) 158
TABLE 102 LONG-TERM CARE & ASSISTED LIVING FACILITIES MARKET, BY REGION,
2022–2030 (USD MILLION) 159
TABLE 103 HOME HEALTHCARE MARKET, BY REGION, 2022–2030 (USD MILLION) 160
TABLE 104 OTHER HEALTHCARE PROVIDERS MARKET, BY REGION,
2022–2030 (USD MILLION) 161
TABLE 105 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PAYERS,
BY REGION, 2022–2030 (USD MILLION) 162
TABLE 106 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PATIENTS, BY REGION,
2022–2030 (USD MILLION) 163
TABLE 107 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION) 164
TABLE 108 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR MEDTECH COMPANIES,
BY REGION, 2022–2030 (USD MILLION) 165
TABLE 109 AI IN TELEHEALTH & TELEMEDICINE MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION) 166
TABLE 110 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY REGION,
2022–2030 (USD MILLION) 168
TABLE 111 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 170
TABLE 112 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 170
TABLE 113 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 170
TABLE 114 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 171
TABLE 115 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 171
TABLE 116 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 172
TABLE 117 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 172
TABLE 118 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 173
TABLE 119 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 173
TABLE 120 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 174
TABLE 121 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 175
TABLE 122 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 175
TABLE 123 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 175
TABLE 124 US: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 176
TABLE 125 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 176
TABLE 126 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 177
TABLE 127 US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 177
TABLE 128 US: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 178
TABLE 129 US: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 178
TABLE 130 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 179
TABLE 131 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 179
TABLE 132 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 180
TABLE 133 CANADA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 180
TABLE 134 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 181
TABLE 135 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 181
TABLE 136 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 182
TABLE 137 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 182
TABLE 138 CANADA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 183
TABLE 139 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 184
TABLE 140 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 184
TABLE 141 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 185
TABLE 142 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 185
TABLE 143 EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 185
TABLE 144 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 186
TABLE 145 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 186
TABLE 146 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 187
TABLE 147 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 187
TABLE 148 EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 188
TABLE 149 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 189
TABLE 150 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 189
TABLE 151 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 189
TABLE 152 GERMANY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 190
TABLE 153 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 190
TABLE 154 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 191
TABLE 155 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 191
TABLE 156 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 192
TABLE 157 GERMANY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 192
TABLE 158 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 193
TABLE 159 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 194
TABLE 160 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 194
TABLE 161 UK: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 194
TABLE 162 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 195
TABLE 163 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 195
TABLE 164 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 165 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 196
TABLE 166 UK: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 197
TABLE 167 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 198
TABLE 168 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 198
TABLE 169 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 198
TABLE 170 FRANCE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 199
TABLE 171 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 199
TABLE 172 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 200
TABLE 173 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 200
TABLE 174 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 201
TABLE 175 FRANCE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 176 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 202
TABLE 177 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 203
TABLE 178 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 203
TABLE 179 ITALY: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 203
TABLE 180 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 204
TABLE 181 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 204
TABLE 182 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 205
TABLE 183 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 205
TABLE 184 ITALY: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 206
TABLE 185 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 207
TABLE 186 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 207
TABLE 187 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 207
TABLE 188 SPAIN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 208
TABLE 189 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 208
TABLE 190 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 209
TABLE 191 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 209
TABLE 192 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 210
TABLE 193 SPAIN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 210
TABLE 194 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 211
TABLE 195 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 211
TABLE 196 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 212
TABLE 197 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 212
TABLE 198 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 213
TABLE 199 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 213
TABLE 200 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 214
TABLE 201 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 214
TABLE 202 REST OF EUROPE: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 215
TABLE 203 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 217
TABLE 204 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 217
TABLE 205 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 217
TABLE 206 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 218
TABLE 207 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 218
TABLE 208 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 219
TABLE 209 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 219
TABLE 210 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 220
TABLE 211 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 220
TABLE 212 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 221
TABLE 213 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 222
TABLE 214 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 222
TABLE 215 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 222
TABLE 216 CHINA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 223
TABLE 217 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 223
TABLE 218 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 224
TABLE 219 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 224
TABLE 220 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 225
TABLE 221 CHINA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 225
TABLE 222 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 226
TABLE 223 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 226
TABLE 224 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 227
TABLE 225 JAPAN: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 227
TABLE 226 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 228
TABLE 227 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 228
TABLE 228 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 229
TABLE 229 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 229
TABLE 230 JAPAN: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 230
TABLE 231 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 231
TABLE 232 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 231
TABLE 233 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 231
TABLE 234 INDIA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 232
TABLE 235 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 232
TABLE 236 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 233
TABLE 237 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 233
TABLE 238 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 234
TABLE 239 INDIA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 234
TABLE 240 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 235
TABLE 241 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 235
TABLE 242 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 236
TABLE 243 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 236
TABLE 244 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2022–2030 (USD MILLION) 237
TABLE 245 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 237
TABLE 246 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 238
TABLE 247 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2022–2030 (USD MILLION) 238
TABLE 248 REST OF ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 239
TABLE 249 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 240
TABLE 250 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 240
TABLE 251 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 241
TABLE 252 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 241
TABLE 253 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 241
TABLE 254 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 242
TABLE 255 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 242
TABLE 256 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 243
TABLE 257 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 243
TABLE 258 LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 244
TABLE 259 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 245
TABLE 260 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 245
TABLE 261 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 246
TABLE 262 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 246
TABLE 263 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 247
TABLE 264 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 247
TABLE 265 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 248
TABLE 266 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 248
TABLE 267 BRAZIL: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 249
TABLE 268 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2022–2030 (USD MILLION) 250
TABLE 269 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 250
TABLE 270 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 250
TABLE 271 MEXICO: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 251
TABLE 272 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2022–2030 (USD MILLION) 251
TABLE 273 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 252
TABLE 274 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 252
TABLE 275 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2022–2030 (USD MILLION) 253
TABLE 276 MEXICO: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDER BY END USER, 2022–2030 (USD MILLION) 253
TABLE 277 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 254
TABLE 278 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 255
TABLE 279 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 255
TABLE 280 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 255
TABLE 281 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2022–2030 (USD MILLION) 256
TABLE 282 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 256
TABLE 283 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 257
TABLE 284 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2022–2030 (USD MILLION) 257
TABLE 285 REST OF LATIN AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET
FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 258
TABLE 286 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY REGION, 2022–2030 (USD MILLION) 259
TABLE 287 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 259
TABLE 288 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 259
TABLE 289 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 260
TABLE 290 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 260
TABLE 291 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2022–2030 (USD MILLION) 261
TABLE 292 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 261
TABLE 293 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 262
TABLE 294 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2022–2030 (USD MILLION) 262
TABLE 295 MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET
FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 263
TABLE 296 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT, 2022–2030 (USD MILLION) 264
TABLE 297 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY MODALITY, 2022–2030 (USD MILLION) 264
TABLE 298 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 264
TABLE 299 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET,
BY DEPLOYMENT, 2022–2030 (USD MILLION) 265
TABLE 300 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION, 2022–2030 (USD MILLION) 265
TABLE 301 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 266
TABLE 302 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 266
TABLE 303 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER, 2022–2030 (USD MILLION) 267
TABLE 304 GCC COUNTRIES: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 267
TABLE 305 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY COMPONENT, 2022–2030 (USD MILLION) 268
TABLE 306 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY MODALITY, 2022–2030 (USD MILLION) 268
TABLE 307 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY INTEGRATION TYPE, 2022–2030 (USD MILLION) 269
TABLE 308 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE SOFTWARE MARKET, BY DEPLOYMENT, 2022–2030 (USD MILLION) 269
TABLE 309 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY FUNCTION, 2022–2030 (USD MILLION) 270
TABLE 310 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY APPLICATION, 2022–2030 (USD MILLION) 270
TABLE 311 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR SPECIALTY CARE APPLICATIONS, BY TYPE, 2022–2030 (USD MILLION) 271
TABLE 312 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET,
BY END USER, 2022–2030 (USD MILLION) 271
TABLE 313 REST OF MIDDLE EAST & AFRICA: AI IN TELEHEALTH & TELEMEDICINE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 272
TABLE 314 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, JANUARY 2021–MARCH 2025 273
TABLE 315 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEGREE OF COMPETITION 278
TABLE 316 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGION FOOTPRINT 282
TABLE 317 AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNCTION FOOTPRINT 283
TABLE 318 AI IN TELEHEALTH & TELEMEDICINE MARKET: APPLICATION FOOTPRINT 284
TABLE 319 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPONENT FOOTPRINT 285
TABLE 320 AI IN TELEHEALTH & TELEMEDICINE MARKET: END-USER FOOTPRINT 286
TABLE 321 AI IN TELEHEALTH & TELEMEDICINE MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 289
TABLE 322 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION 289
TABLE 323 AI IN TELEHEALTH & TELEMEDICINE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MARCH 2025 292
TABLE 324 AI IN TELEHEALTH & TELEMEDICINE MARKET: DEALS,
JANUARY 2022–MARCH 2025 293
TABLE 325 MEDTRONIC: COMPANY OVERVIEW 294
TABLE 326 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 296
TABLE 327 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–MARCH 2025 297
TABLE 328 MEDTRONIC: DEALS, JANUARY 2022–MARCH 2025 298
TABLE 329 TELADOC HEALTH, INC.: COMPANY OVERVIEW 300
TABLE 330 TELADOC HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 302
TABLE 331 TELADOC HEALTH, INC.: PRODUCT LAUNCHES AND UPGRADES,
JANUARY 2022–MARCH 2025 303
TABLE 332 TELADOC HEALTH, INC.: DEALS, JANUARY 2022–MARCH 2025 304
TABLE 333 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 306
TABLE 334 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 307
TABLE 335 KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS, JANUARY 2022–MARCH 2025 309
TABLE 336 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–MARCH 2025 309
TABLE 337 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 311
TABLE 338 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 313
TABLE 339 CISCO SYSTEMS, INC.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 314
TABLE 340 CISCO SYSTEMS, INC.: DEALS, JANUARY 2022–MARCH 2025 314
TABLE 341 GE HEALTHCARE: COMPANY OVERVIEW 316
TABLE 342 GE HEALTHCARE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 318
TABLE 343 GE HEALTHCARE: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–MARCH 2025 319
TABLE 344 GE HEALTHCARE: DEALS, JANUARY 2022–MARCH 2025 319
TABLE 345 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 321
TABLE 346 EPIC SYSTEMS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 322
TABLE 347 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 323
TABLE 348 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2022–MARCH 2025 324
TABLE 349 ORACLE: COMPANY OVERVIEW 325
TABLE 350 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 327
TABLE 351 ORACLE: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 328
TABLE 352 ORACLE: DEALS, JANUARY 2022–MARCH 2025 329
TABLE 353 DOXIMITY, INC.: COMPANY OVERVIEW 331
TABLE 354 DOXIMITY, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 332
TABLE 355 DOXIMITY, INC.: PRODUCT UPGRADES, JANUARY 2022–MARCH 2025 333
TABLE 356 DOXIMITY, INC.: DEALS, JANUARY 2022–MARCH 2025 333
TABLE 357 DOXIMITY, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 334
TABLE 358 INCLUDED HEALTH, INC.: COMPANY OVERVIEW 335
TABLE 359 INCLUDED HEALTH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 335
TABLE 360 INCLUDED HEALTH, INC.: DEALS, JANUARY 2022–MARCH 2025 336
TABLE 361 INCLUDED HEALTH, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 337
TABLE 362 ZOOM COMMUNICATIONS, INC.: COMPANY OVERVIEW 338
TABLE 363 ZOOM COMMUNICATIONS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 339
TABLE 364 ZOOM COMMUNICATIONS, INC.: DEALS, JANUARY 2022–MARCH 2025 340
TABLE 365 AMERICAN WELL: COMPANY OVERVIEW 341
TABLE 366 AMERICAN WELL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 342
TABLE 367 AMERICAN WELL: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 343
TABLE 368 AMERICAN WELL: DEALS, JANUARY 2022–MARCH 2025 344
TABLE 369 AMERICAN WELL: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 344
TABLE 370 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 345
TABLE 371 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 346
TABLE 372 SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS,
JANUARY 2022–MARCH 2025 347
TABLE 373 AMC HEALTH: COMPANY OVERVIEW 348
TABLE 374 AMC HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 348
TABLE 375 AMC HEALTH: DEALS, JANUARY 2022–MARCH 2025 349
TABLE 376 TELESPECIALISTS: COMPANY OVERVIEW 350
TABLE 377 TELESPECIALISTS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 350
TABLE 378 TELESPECIALISTS: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 351
TABLE 379 TELESPECIALISTS: DEALS, JANUARY 2022–MARCH 2025 351
TABLE 380 TELESPECIALISTS: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 352
TABLE 381 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY OVERVIEW 353
TABLE 382 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCTS/SERVICES/SOLUTIONS OFFERED 354
TABLE 383 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 355
TABLE 384 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): EXPANSIONS, JANUARY 2022–MARCH 2025 355
TABLE 385 CAREGILITY: COMPANY OVERVIEW 356
TABLE 386 CAREGILITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 356
TABLE 387 CAREGILITY: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 357
TABLE 388 CAREGILITY: DEALS, JANUARY 2022–MARCH 2025 357
TABLE 389 CAREGILITY: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 358
TABLE 390 CVS HEALTH: COMPANY OVERVIEW 359
TABLE 391 CVS HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 360
TABLE 392 CVS HEALTH: PRODUCT LAUNCHES AND UPGRADES, JANUARY 2022–MARCH 2025 361
TABLE 393 ALIVECOR, INC.: COMPANY OVERVIEW 362
TABLE 394 ALIVECOR, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 362
TABLE 395 ALIVECOR, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022–MARCH 2025 363
TABLE 396 ALIVECOR, INC.: DEALS, JANUARY 2022–MARCH 2025 364
TABLE 397 ALIVECOR, INC.: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025 365
TABLE 398 ELATION: COMPANY OVERVIEW 366
TABLE 399 ELATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 366
TABLE 400 ELATION: DEALS, JANUARY 2022–MARCH 2025 367
TABLE 401 HEALTHTAP, INC.: COMPANY OVERVIEW 368
TABLE 402 HEALTHTAP, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 368
TABLE 403 HEALTHTAP, INC.: PRODUCT LAUNCHES, JANUARY 2022–MARCH 2025 369
TABLE 404 HEALTHTAP, INC.: DEALS, JANUARY 2022–MARCH 2025 369
TABLE 405 CURAI HEALTH: COMPANY OVERVIEW 370
TABLE 406 ANDOR HEALTH: COMPANY OVERVIEW 371
TABLE 407 K HEALTH: COMPANY OVERVIEW 372
TABLE 408 TRANSACARENT: COMPANY OVERVIEW 373
TABLE 409 BIOINTELLISENSE, INC.: COMPANY OVERVIEW 374
LIST OF FIGURES
FIGURE 1 AI IN TELEHEALTH & TELEMEDICINE MARKET: SEGMENTS CONSIDERED & GEOGRAPHICAL SCOPE 36
FIGURE 2 AI IN TELEHEALTH & TELEMEDICINE MARKET: YEARS CONSIDERED 38
FIGURE 3 AI IN TELEHEALTH & TELEMEDICINE MARKET: RESEARCH DESIGN 41
FIGURE 4 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM SECONDARY SOURCES 43
FIGURE 5 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY PRIMARY SOURCES 44
FIGURE 6 AI IN TELEHEALTH & TELEMEDICINE MARKET: KEY DATA FROM PRIMARY SOURCES 45
FIGURE 7 AI IN TELEHEALTH & TELEMEDICINE MARKET: INSIGHTS FROM PRIMARIES 46
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 46
FIGURE 9 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 47
FIGURE 10 AI IN TELEHEALTH & TELEMEDICINE MARKET: TOP-DOWN APPROACH 48
FIGURE 11 AI IN TELEHEALTH & TELEMEDICINE MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
(2024–2030) 50
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
FIGURE 13 AI IN TELEHEALTH & TELEMEDICINE MARKET: DATA TRIANGULATION 52
FIGURE 14 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY COMPONENT,
2024 VS. 2030 (USD MILLION) 55
FIGURE 15 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY FUNCTION,
2024 VS. 2030 (USD MILLION) 56
FIGURE 16 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY APPLICATION,
2024 VS. 2030 (USD MILLION) 57
FIGURE 17 AI IN TELEHEALTH & TELEMEDICINE MARKET, BY END USER,
2024 VS. 2030 (USD MILLION) 58
FIGURE 18 AI IN TELEHEALTH & TELEMEDICINE MARKET: REGIONAL SNAPSHOT 59
FIGURE 19 TECHNOLOGICAL ADVANCEMENTS AND NEED TO REDUCE HEALTHCARE EXPENSES TO PROPEL MARKET GROWTH 60
FIGURE 20 US AND SOFTWARE SEGMENT DOMINATED NORTH AMERICAN MARKET IN 2023 61
FIGURE 21 CHINA TO REGISTER HIGHEST CAGR FROM 2024 TO 2030 62
FIGURE 22 EMERGING MARKETS TO GROW AT HIGHER RATES DURING STUDY PERIOD 63
FIGURE 23 AI IN TELEHEALTH & TELEMEDICINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
FIGURE 24 AMERICAN HOSPITAL ASSOCIATION (AHA) ANNUAL SURVEY ON EHR ADOPTION AMONG HOSPITALS AND OFFICE-BASED PHYSICIANS (2008–2021) 67
FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009–2024 73
FIGURE 26 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES IN US, 2009–2023 73
FIGURE 27 AI IN TELEHEALTH & TELEMEDICINE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 76
FIGURE 28 AI IN TELEHEALTH & TELEMEDICINE MARKET: ECOSYSTEM ANALYSIS 77
FIGURE 29 AI IN TELEHEALTH & TELEMEDICINE MARKET: VALUE CHAIN ANALYSIS 79
FIGURE 30 AI IN TELEHEALTH & TELEMEDICINE MARKET: PORTER’S FIVE FORCES ANALYSIS 100
FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR
TOP FOUR END USERS 102
FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE COMPONENTS 103
FIGURE 33 GLOBAL PATENT PUBLICATION TRENDS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES, 2015–2025 104
FIGURE 34 JURISDICTION & TOP APPLICANT ANALYSIS FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES 105
FIGURE 35 TOP APPLICANTS/OWNERS (COMPANIES/INSTITUTIONS) FOR AI-BASED TELEHEALTH & TELEMEDICINE DEVICES (JANUARY 2015–MARCH 2025) 106
FIGURE 36 AI IN TELEHEALTH & TELEMEDICINE MARKET: FUNDING AND NUMBER
OF DEALS, 2021–2024 111
FIGURE 37 NORTH AMERICA: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 169
FIGURE 38 ASIA PACIFIC: AI IN TELEHEALTH & TELEMEDICINE MARKET SNAPSHOT 216
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET, 2020–2024 (USD MILLION) 276
FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN AI IN TELEHEALTH & TELEMEDICINE MARKET (2023) 277
FIGURE 41 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 280
FIGURE 42 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY FOOTPRINT 281
FIGURE 43 AI IN TELEHEALTH & TELEMEDICINE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 288
FIGURE 44 EV/EBITDA OF KEY AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024 290
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND A 5-YEAR STOCK BETA OF
AI-BASED TELEHEALTH & TELEMEDICINE PLAYERS, 2024 290
FIGURE 46 AI IN TELEHEALTH & TELEMEDICINE MARKET: BRAND/SOFTWARE
COMPARATIVE ANALYSIS 291
FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT 295
FIGURE 48 TELADOC HEALTH, INC.: COMPANY SNAPSHOT 301
FIGURE 49 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 307
FIGURE 50 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT 312
FIGURE 51 GE HEALTHCARE: COMPANY SNAPSHOT 317
FIGURE 52 ORACLE: COMPANY SNAPSHOT 326
FIGURE 53 DOXIMITY, INC.: COMPANY SNAPSHOT 332
FIGURE 54 ZOOM COMMUNICATIONS, INC.: COMPANY SNAPSHOT 339
FIGURE 55 AMERICAN WELL: COMPANY SNAPSHOT 342
FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 346
FIGURE 57 WALGREENS BOOTS ALLIANCE, INC. (WALGREEN CO.): COMPANY SNAPSHOT 354
FIGURE 58 CVS HEALTH: COMPANY SNAPSHOT 360
